SLC1A3 variant associated with hemiplegic migraine and acetazolamide-responsive MRS changes
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received December 19, 2019
- Accepted in final form May 28, 2020
- First Published July 7, 2020.
Author Disclosures
- Martin Paucar, MD, PhD,
- Tobias Granberg, MD, PhD,
- Kristina Lagerstedt-Robinson, PhD,
- Elisabet Waldenlind, MD, PhD,
- Sven Petersson, PhD,
- Love Nordin, PhD and
- Per Svenningsson, MD, PhD
- Martin Paucar, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Stockholm Region
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Tobias Granberg, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Research grants, 3 years, Stockholm Region and Karolinska Institutet (ALF 20170036, CIMED 20190565).
NONE
Research grant, 4 years, The Swedish Society for Medical Research. Research grant, The Christer Lindgren and Eva Fredholm Foundation.
NONE
NONE
NONE
NONE
NONE
NONE
- Kristina Lagerstedt-Robinson, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Elisabet Waldenlind, MD, PhD,
NONE
NONE
Payment 15,000 SEK by Novartis for 3 lectures october 2019 given for the Swedish Headache Sociaty. Novartis sponsored the lectures
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Sven Petersson, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Love Nordin, PhD and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Per Svenningsson, MD, PhD
CBD solutions AB
NONE
Sanofi Genzyme, Shire
PLoS ONE, Academic editor, 2012-2017 Neuropharmacology, Academic editor, 2016-2017
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Swedish Research Council 2016_2019 ALF Stockholm 2017_2019 Wallenberg Clinical Scholar 2017_2021
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology (M.P., E.W., P.S.), Karolinska University Hospital; Department of Clinical Neuroscience (M.P., T.G., E.W., P.S.), Karolinska Institutet; Department of Neuroradiology (T.G.), Karolinska University Hospital; Department of Molecular Medicine and Surgery (K.L.-R.), Karolinska Institutet; Department of Clinical Genetics (K.L.-R.); Medical Radiation Physics and Nuclear Medicine (S.P., L.N.), Karolinska University Hospital; and Division of Clinical Geriatrics (L.N.), Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
- Correspondence
Dr. Paucar martin.paucar-arce{at}sll.se
Article usage
Letters: Rapid online correspondence
NOTE: All contributors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.ng.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Related Articles
- No related articles found.